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and no new lesions developed. Literature review illustrated this is a rare
complication ofTx immunosuppression and there is no clear consensus on
duration of treatment. We suggest the need for aggressive management of
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IM0071 Bacterial infections induce a stimulus-related
transcription of the calcitonin precursor gene CALC·1
E. Nylen, B. Muller, R. Snider, M. Hussain. K. Wagner.J. White. K.
Becker, J. Habener
VAMC, George Washington Univ., Georgetown Univ. Washington, nc.,
United States; Univ Basel, Switzerland; Mass. General Hospital, Boston,
United States
Objective: CALC-I gene transcription gives rise to a family of cireulating
peptides including thyroid C-cell calcitonin (CT) and several calcitonin
preeursors (CTpr). In systemic infections. there is massive elaboration of
CTpr but no corresponding increase in CT. Furthermore, CTpr per se is
toxic to animals and immunoneutralization improves their survival. The
origin of CTpr remains to be clarified.
Methods: A hamster model oflethal E. coli peritonitis was used for peptide
(RIA) and CT mRNA (RT-PCR and in situ hybridization) determinations.
Results: In septic animals. high molecular weight CT (i.e.• CTpr) was
produced in a variety of organs (e.g., liver. lung. kidney) as well as being
detected in the serum. By R T-PCR, CTmRNA was expressed in a variety
ofseptic tissues but absent in most healthy control tissues. In situ hybridiza-
tion revealed the presence ofCT mRNA in many tissues and cell types.
Conclusions: In experimental sepsis. CT gene expression is ubiquitously
distributed. CTpr constitute a diffuse network ofrelated peptides that, in the
presence of systemic infection. are preferrentially mobilized and discharged
in a stimulus-specific manner. Importantly. since our prior studies showed
that the immunoneutralization of CTpr enhances survival, uncovering the
molecular mechanisms regulating CALC-I transcription may reveal novel
treatment approaches to sepsis.
IMoOSIRegulation of toxin production in Oostrldium didle is
connected with Its energy metabolism
S. Karlsson
,
,4, T. Akerlundl , E. Norin2 • C. EdIundJ • L. G. Burman'
1Swedish Instfor Inf Dis Control; 2Dept ofMi{robial E{ology, Karolinska Inst;
JDept ofMilrobiology at Huddinge, Karolinska Inst; 4Dept ofMi{robiology and
Tumor Biology, Karolinska Inst, Sto{kholm, Sweden
Background: Toxin positive strains of C. dijJitile may differ up to 100 000-
fold in toxin production. but the mode ofregulation ofits two (toxin A and
B) genes is not known. Toxin production is up regulated by biotin limiration
and in glucose free rich media. and down regulated by addition ofglucose or
a mix of9 growth promoting amino acids.
Material and Methods: Production oftoxins, metabolic end products (short
chain fatty acids. alcohols, acetone) and cell protein patterns of various C.
dijJitile strains during different growth conditions were studied by immu-
noassay. GLC and 2-D PAGE, respectively. PCR amplified toxin gene
promoter DNA bound to magnetic Dynabeads was used for affinity
isolation of promoter binding proteins. Proteins were identified by N-
terminal amino acid sequencing and dara base searches.
Results: Among the 9 amino acids cysteine was the most potent suppressor
of C. dijJitile toxin production both in vitro and ex vivo (in diluted human
feces). Up regulation of toxin production was associated with switched on
synthesis of several merabolic enzymes plus an electron carrier protein and
with a changed pattern of metabolic end products. The enzyme 3-0H-
butyryl-CoenzymeA-dehydrogenase was not only up regulated bUI also
bound to the toxin A and B gene promoters (but not to unrelated DNA)
during high toxin production. linking a change ofbacterial merabolism with
toxin expression in C. dijJitile.
conclusion: We hypothesize that certain merabolic stress leads 10 altered
metabolism. ATP and end product levels. and switching on the toxin A and
B genes in C. dijJitile, whereas overnutrition ofthe organism has the opposite
effect. Administration ofe.g. cysteine to the large bowel may become a new
approach to prophylaxis and therapy of C. dijJitile diarrhea.
superficial mycoses both pre and post Tx as well as prolonged treatment of
established infections.
IMoOgl Eap (extracellular adherence protein), an adherence
enhancement protein from Staphylococcus aurues
Axana Haggar, Marco Palma. J. -I. Flock
Dept ojClini{al Batteriology, Karolinska Institutet, Stotkholm, Sweden
Objectives: To investigate the role that Eap plays in the process ofS. aureus's
binding to host cells.
Methods: Purification of Eap was done from S. aureus supernarants using
affinity chromatography followed by ion exchange chromatography.
Adherence of Eap to fibroblasts. epithelial and enodothelial cells were
measured by I2SI_labelled Eap. Adherence of S. aureus to fibroblasts and
epithelial cells was done for one hour onto confluent layers of cells. Binding
was determined microscopically.
Result The binding of S. aureus to host tissues is multifactorial. Plasma
binding proteins produced by the bacteria play a crucial role for the
attachment of S. aureus to the host. Eap (extracellular adherence protein) a
plasma binding prolein contribute to this process. Eap form oligomers.
rebind and agglutinate the bacteria. This protein can bind to seven plasma
proteins among which we found fibronectin. fibrinogen and prothrombin.
Eap binds 10 eukaryotic cells with aprox. 7 x 106 Eap moleeules/cell. The
adherence enhancement resulting from Eap is dose dependent and increase
the binding of the bacteria 5 times.
Condusion: The enhancement of adherence seen in this study is due to the
ability of Eap to bind both to host plasma proteins and to the surface ofS.
aureus. It thereby forms a bridge between the cukaryotie cell and the
bacterium.
IMo010 ISurveillance of invasive pneumococcal disease in the
US Arctic and sub Arctic Alaska 1986-1998
A.J. Parkinson. K. Rudolph, A. Reasonover, L. R. Bulkow,J. C. Butler
CDC, Arttit Investigations Program, Anchorage, Alaska, United States
Objectives: Surveillance of invasive pneumococcal disease was established
in Alaska in 1986 to; I) evaluate rates of disease in both Native and non
Native segments ofthe population, 2) determine the serotype distribution. in
preparation for vaccine programs. and 3) monitor and control antimicrobial
resistance.
Methods: Invasive pneumococcal isolates collected between 1986 and 1998
from Alaska Natives and non Natives from 23 hospital laboratories were
serotyped. and tested for antibiotic susceptibility by agar dilution. More than
40% of the 1620 sterile site isolates were from Alaska Natives whieh
constitute < 20% of the total population.
Results: Invasive disease rates based on culture were 62 and 16 cases/l00.000
respectively for Native and non Natives. Scrotyping confirmed that 92%
were contained in the 23 valent vaccine. Among Native and non Native
children < 2 years of age rates were 450 and 129/100,000 respectively.
Serotypes in the 7 valent conjugate vaccine were recovered from 73% and
83% ofisolates from Native and non Native children < 2 years respectively.
Overall reduced susceptibility to penicillin (MIC > 0.1 - < 2 ug/mI) was
found in 10.5% ofisolates, and 3.2% were fully resisrant (MIC > 2 ug/ml).
In 1986 only 2.5% of isolates had reduced penicillin susceptibility and none
were resistant. However in 1998, 6.8% had reduced susceptibility, and an
additional 6.2% were fully resistant.
Conduslons: High rates of invasive pneumococcal disease are found in Ihc
Alaska Native population. and the emergence ofantibiotic resisrance in this
population now complicates treatment. Efforts to reduce the disease burden
and control antibiotic resisrance include continued surveillance. use of
vaccines. and education of communities and health care providers on
appropriate antibiotic use.
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IMo0111 Vegetation due to StreptococcuS viridans in
pulmonary artery In a child with patent Ductus arteriosus
G. Yetkin, E. Yetkin1, A. Yanik l, M. I1erit, A. Mert, S. Goksell
SSK Educational Hospital Departmmt ofMicrobiology; 1TYIH Department of
Cardiology, Ankara, Turkey
Objectives: The risk of infective endocarditis has been ceased by the
devolepment of succesfull ligation of the ductus in patients with patent
ductus arteriosus (PDA). There are only a few cases in which the vegetation
has been shown by either in postmortem studies or in echocardiographic
evaluation.
Case report: A 12 years old child was admitted to the hospital by the
complaints of exertional dyspnea for 2 months, palpitalion, coughing and
fever lasting for 2 weeks. There were no more systemic examination findings
except the continuous murmur below the left clavicula. In parasternal short
axis view, just proximal to the bifurcation of the pulmonary artery, at the
opening side of the patent ductus arteriosus, 19-9 mm in size and highly
mobile vegetation was demonstrated by echocardiographic examination
Streptococcus viridans was isolated from the child's blood culture and
sensitive to the both antibiotic (penicilline and gentamisine).ln echocardio-
graphic evaluation one week after starting the antibiotic treatment, a clear
decrease in vegetation size (11-5 mm) was demonstrated. At the end of the
one mounth there was no detectable vegetation by echocardiography.
During this period, the child didn't show the clinical signs of pulmonary
embolism. and the child had an uncomplicated ductus ligation operation.
Discussion: With the introduction of antibiotics and surgical treatment,
there has been a manifest reduction in the number of cases of PDA
complicated by infective endarteritis, and the risk of death has been
considerably reduced. In patient with infective endarteritis associated with
a patent ductus arteriosus, the infective vegetation is usually seen at the
pulmonary end ofthe ductus as in our case. The interest ofthis case lies in the
association of a PDA and a vegetation in the pulmonary artery and
disappearance of the vegatation at the end of the one month antibiotic
treatment. The risk of infective endarteritis is still prevelant even in a small
ductus.
IMo0121 Uver abscess in Sheeld over 10 years
A. Mohsen, S. Green, M. W. McKendrick
Royal Hallamshi,. Hospital, Sheffield, United Kingdom
Objectlves: To review the epidemiology, aetiology and management of
liver abscess.
Methods: We have reviewed retrospectively the clinical notes of67 patients
with a coded discharge diagnosis ofliver abscess admitted to a large teaching
hospital over the last 10 years.
Results: The incidence was 13/100,000 hospital admission, mean age of63.5
years (range 17-91). 29 were male. The mean time from presentation to
diagnosis was 5 days (range 0-28) with an average duration ofadmission of
23 days. 50/67 (75%) were pyrexial at presentation. 19 patients (28%) had
normal enzymes (ALT, Alk-p). 64 patients had an ultrasound (V/S). The
abscess was diagnosed by U /S in 58 (87%), CT Scan in 5 (7%) and surgically
or postmortem in 4 (5%). An aetiological agent was identified in 50 (75%)
patients. Polymicrobial bacterial infection was identified in 22%. Strepto-
coccus (44%), gram negative bacilli (25%), anaerobes (24%), and 6 had
positive amoebic serology. Underlying bowel disease was identified in 34/67
patients. 17% were taking antacids on admission to hospital. The majority of
patients were treated successfully with antibiotics (average 28 days) and
ultrasound-guided percutaneous aspiration/drainage. 7/67 episodes were
treated via laparotomy. 7/67 patients died (10%), most of whom had
neoplastic disease.
Conduslon: Liver abscess should be considered early in patients presenting
with undifferentiated fever and early U/S performed. Endoscopic investiga-
tion of the gastrointestinal tracts often reveals related abnormalities. Ofnote
in this series was antacid use and upper GI pathology which may have
facilitated bacterial overgrowth in the upper GI tract. Mortality was most
common in patients with intestinal or immunological co-morbidities.
IMo013! Lack of relation between Chlamydia pneumoniae
serology and atherosclerotic carotid disease
J. de Oterol, M. Paz2, M. Gayal, C. Pueyol, B. Oms3, A. Salvad63, P.
Codinach2, F de B. Ferrer-Ruscalleda1
1Internal Medicine; 2Cardiology; 3Neurology Departments, Hospital Creu
Roja, Barcelona, Spain
Objectives: Infection with Chlamydia pneumoniae (Cp) is associated with
atherosclerotic coronary disease. Our aim was to evaluate a possible
association between Cp and atherosclerosis at other sites, specifically athero-
sclerotic carotid disease (ACD).
Methods: We conducted a case-control study: patients with confirmed
ACD (duplex scanner) as cases and age-sex matched controls. Controls had
no symptoms of carotid or peripheral vascular diseases, and calcific valvular
(aortic) affection was ruled-out (doppler echocardiogram). Baseline char-
acteristics were recorded. Serum-specific IgG antibodies to Cp were deter-
mined by ELISA technique. A titer ~ 1:80 was considered positive.
Comparisons between cases and controls were made using X2 or Mann-
Whimey's U tests. A p < 0.05 was considered significative.
Results: 88 patients (54 men) with a median age of73.5 years (range 30-93)
were included. Of them, 53 (60.2%) were controls. Baseline characteristics
were comparable between groups. IgG antibodies were positive in 43
(48.86%) patients: 13 cases and 30 controls (p NS). No difference was
found considering only positivity at high titers oflgG: 12 controls ~ 1:160 vs
6 cases, and 7 controls ~ 1:320 vs 4 cases (p NS). No difference was observed
comparing medians (only positive titers).
Condusions: 1. No relation was found between titers of IgG antibodies to
Cp and the presence of ACD. 2. It must be ruled out iflgG antibodies are
enough sensitive to study a possible role of CP in ACD. 3. It should be
interesting to inquire into new markers (as the PCR) of vascular Cp
infection.
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[MoP1031 Primary meningococcal pneumonia, an
underestimated entity. Problem for diagnosis and prophylaxis
L. Lerousseaul , V. Blancl,J. M. Alonso2,J. M. Chavaillonl
I Hopital d'Antibes; 2Instilut Pasteur, 75 Paris, Frame
Because of controversial diagnosis, primary meningoccocal pneumonia,
though reported as early as 1906, is usually underestimated. We report a
case ofpneumonia due to Neisseria meningitidis (N.m.), without concomi-
tant meningeal involvement, attested by strong bacteriological features. A
49 year-old man was admitted with clinical and radiological evidence of
lower right lobe pneumonia. Investigations revealed a white cell count of
12.109J1 (90% polymorphonuclears) and a rise ofC reactive protein to 131
mgJl. Direct examination ofpurulent sputum showed monomicrobial flora
with numerous intra and extra cellular Gram-negative diplococci. Cultures
only grew abundant (> 107/ml) colonies of N.m. serogroup B (the most
prominent serogroup in systemic meningococcal infections in France), of
normal susceptibility to penicillin G. No other pathogens were isolated and
atypical pneumonia serology was subsequently reported to be negative.
Blood and cerebro-spinal Buid cultures remained sterile. Treatment was
started with amoxicillin and led to full recovery within 7 days. Prophylaxis
was not offered to close contacts but septic isolation and secondary
prophylaxis ofthe patient was instaured. No secondary cases were observed.
N.m. is a commensal of upper respiratory tract and is usually not held
responsible for lower-tract respiratory infections. Therefore, the frequency
of primary pneumonia might be underestimated. Lack of specific clinical
features, ofsystematic sampling, ofconsensual bacteriological criteria, and of
mandatory publication may also contribute to underdiagnosis. Nevertheless,
high bacteriological arguments allowed us to consider N.m. as responsible
for this case ofpneumonia. In France, recommendations aiming at lowering
the risk of secondary cases are limited to meningitis and septicemia. As
regards the risk ofselection ofresistant strains, we did not offer prophylaxis
to close contacts, but considering cough as an efficient way to transmit a
virulent strain, we opted for secondary prophylaxis and septic isolation of
the source patient. Meningoccocal pneumonia does exist, common treat-
ment remains widely effective, but diagnosis and prophylactic attitude
remain cleary incomplete.
